Skip to main content
NCBI home page
Journal of Clinical Pathology. Supplement (Royal College of Pathologists) logoLink to Journal of Clinical Pathology. Supplement (Royal College of Pathologists)
. 1979;13:15–22. doi: 10.1136/jcp.s3-13.1.15

Mechanisms in secondary hypogammaglobulinaemia.

P G Riches, J R Hobbs
PMCID: PMC1521589  PMID: 391824

Full text

PDF
15

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSEN S. B. METABOLISM OF GAMMA-SS GLOBULIN IN SECONDARY HYPOGAMMAGLOBULINEMIA. Am J Med. 1963 Nov;35:708–714. doi: 10.1016/0002-9343(63)90141-4. [DOI] [PubMed] [Google Scholar]
  2. ASKONAS B. A., WHITE R. G. Sites of antibody production in the guinea-pig; the relation between in vitro synthesis of anti-ovalbumin and gamma-globulin and distribution of antibody-containing plasma cells. Br J Exp Pathol. 1956 Feb;37(1):61–74. [PMC free article] [PubMed] [Google Scholar]
  3. BARTH W. F., WOCHNER R. D., WALDMANN T. A., FAHEY J. L. METABOLISM OF HUMAN GAMMA MACROGLOBULINS. J Clin Invest. 1964 Jun;43:1036–1048. doi: 10.1172/JCI104987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BRAMBELL F. W., HEMMINGS W. A., MORRIS I. G. A THEORETICAL MODEL OF GAMMA-GLOBULIN CATABOLISM. Nature. 1964 Sep 26;203:1352–1354. doi: 10.1038/2031352a0. [DOI] [PubMed] [Google Scholar]
  5. Broder S., Humphrey R., Durm M., Blackman M., Meade B., Goldman C., Strober W., Waldmann T. Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells. N Engl J Med. 1975 Oct 30;293(18):887–892. doi: 10.1056/NEJM197510302931801. [DOI] [PubMed] [Google Scholar]
  6. Byron P. R., Mallick N. P., Taylor G. Immune potential in human uraemia. 1. Relationship of glomerular filtration rate to depression of immune potential. J Clin Pathol. 1976 Sep;29(9):765–769. doi: 10.1136/jcp.29.9.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Byron P. R., Mallick N. P., Taylor G. Immune potential in human uraemia. 2. Changes after regular haemodialysis therapy. J Clin Pathol. 1976 Sep;29(9):770–772. doi: 10.1136/jcp.29.9.770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chatterjee S. N. Antirejection drugs and procedures. Am J Surg. 1973 Nov;126(5):678–682. doi: 10.1016/s0002-9610(73)80021-2. [DOI] [PubMed] [Google Scholar]
  9. Chen Y., Bhoopalam N., Yakulis V., Heller P. Changes in lymphocyte surface immunoglobulins in myeloma and the effect of an RNA-containing plasma factor. Ann Intern Med. 1975 Nov;83(5):625–631. doi: 10.7326/0003-4819-83-5-625. [DOI] [PubMed] [Google Scholar]
  10. Claman H. N. Corticosteroids and lymphoid cells. N Engl J Med. 1972 Aug 24;287(8):388–397. doi: 10.1056/NEJM197208242870806. [DOI] [PubMed] [Google Scholar]
  11. DRIVSHOLM A. TURNOVER RATE OF PARAPROTEINS IN MYELOMATOSIS. STUDIES ON THE TURNOVER RATE OF SERUM PARAPROTEINS AFTER LABELLING IN VIVO, WITH SPECIAL REFERENCE TO REPEATED TURNOVER-RATE DETERMINATIONS. Acta Med Scand. 1964 Sep;176:257–267. [PubMed] [Google Scholar]
  12. FAIRLEY G. H., SCOTT R. B. Hypogammaglobulinaemia in chronic lymphatic leukaemia. Br Med J. 1961 Oct 7;2(5257):920–924. doi: 10.1136/bmj.2.5257.920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. FUDENBERG H. H., FUDENBERG B. R. ANTIBODY TO HEREDITARY HUMAN GAMMA-GLOBULIN (GM) FACTOR RESULTING FROM MATERNAL-FETAL INCOMPATIBILITY. Science. 1964 Jul 10;145(3628):170–171. doi: 10.1126/science.145.3628.170. [DOI] [PubMed] [Google Scholar]
  14. Fudenberg H. H. Immunologic deficiency, autoimmune disease, and lymphoma: observations, implications, and speculations. Arthritis Rheum. 1966 Jun;9(3):464–472. doi: 10.1002/art.1780090310. [DOI] [PubMed] [Google Scholar]
  15. Giacomoni D., Yakulis V., Wang S. R., Cooke A., Dray S., Heller P. In vitro conversion of normal mouse lymphocytes by plasmacytoma RNA to express idiotypic specificities on their surface characteristic of the plasmacytoma immunoglobulin. Cell Immunol. 1974 Mar 30;11(1-3):389–400. doi: 10.1016/0008-8749(74)90037-9. [DOI] [PubMed] [Google Scholar]
  16. Giangiacomo J., Cleary T. G., Cole B. R., Hoffsten P., Robson A. M. Serum immunoglobulins in the nephrotic syndrome. A possible cause of minimal-change nephrotic syndrome. N Engl J Med. 1975 Jul 3;293(1):8–12. doi: 10.1056/NEJM197507032930103. [DOI] [PubMed] [Google Scholar]
  17. Good R. A., Jose D. Immunodeficiency secondary to nutritional deprivation: clinical and laboratory observations. Birth Defects Orig Artic Ser. 1975;11(1):219–222. [PubMed] [Google Scholar]
  18. HUME D. M., MERRILL J. P., MILLER B. F., THORN G. W. Experiences with renal homotransplantation in the human: report of nine cases. J Clin Invest. 1955 Feb;34(2):327–382. doi: 10.1172/JCI103085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Heller P., Bhoopalam N., Cabana V., Costea N., Yakulis V. The role of RNA in the immunological deficiency of plasmacytoma. Ann N Y Acad Sci. 1973 May 31;207:468–480. doi: 10.1111/j.1749-6632.1973.tb47509.x. [DOI] [PubMed] [Google Scholar]
  20. Hobbs J. R., Davis J. A. Serum gamma-G-globulin levels and gestational age in premature babies. Lancet. 1967 Apr 8;1(7493):757–759. doi: 10.1016/s0140-6736(67)91369-4. [DOI] [PubMed] [Google Scholar]
  21. Hobbs J. R. Growth rates and responses to treatment in human myelomatosis. Br J Haematol. 1969 Jun;16(6):607–617. doi: 10.1111/j.1365-2141.1969.tb00441.x. [DOI] [PubMed] [Google Scholar]
  22. Hobbs J. R., Hepner G. W. Immunolgobulins and alimentary disease. Lancet. 1968 Jul 6;2(7558):47–47. doi: 10.1016/s0140-6736(68)92917-6. [DOI] [PubMed] [Google Scholar]
  23. Hobbs J. R. Immunoglobulins in clinical chemistry. Adv Clin Chem. 1971;14:219–317. doi: 10.1016/s0065-2423(08)60147-x. [DOI] [PubMed] [Google Scholar]
  24. Hobbs J. R. Paraproteins, benign or malignant? Br Med J. 1967 Sep 16;3(5567):699–704. doi: 10.1136/bmj.3.5567.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hobbs J. R. Secondary antibody deficiency. Proc R Soc Med. 1968 Sep;61(9):883–887. doi: 10.1177/003591576806100913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Katzmann J. A. Myeloma-induced immunosuppression: a multistep mechanism. J Immunol. 1978 Oct;121(4):1405–1409. [PubMed] [Google Scholar]
  27. Krakauer R. S., Strober W., Waldmann T. A. Hypogammaglobulinemia in experimental myeloma: the role of suppressor factors from mononuclear phagocytes. J Immunol. 1977 Apr;118(4):1385–1390. [PubMed] [Google Scholar]
  28. Lagrue G., Xheneumont S., Branellec A., Weil B. Letter: Lymphokines and nephrotic syndrome. Lancet. 1975 Feb 1;1(7901):271–272. doi: 10.1016/s0140-6736(75)91164-2. [DOI] [PubMed] [Google Scholar]
  29. Littlewood J. M., Hunter I., Payne R. B., Miles D. W. Placental transfer of an IgG paraprotein associated with prolonged immunosuppression. Br Med J. 1970 Oct 10;4(5727):94–95. doi: 10.1136/bmj.4.5727.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Littlewood J. M., Payne R. B. Placental transfer of IgG paraprotein with prolonged immunosuppression. Br Med J. 1977 Jan 29;1(6056):291–291. doi: 10.1136/bmj.1.6056.291-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. MacKenzie M. R., Paglieroni T. Multiple myeloma: an immunologic profile. I. Peripheral blood studies. J Immunol. 1977 May;118(5):1864–1871. [PubMed] [Google Scholar]
  32. Moscatelli P., Dagna Bricarelli F., De Barbieri A. Immunoglobulins on the surface of lymphocytes, their distribution in cord blood, newborns and infants affected by transient hypogammaglobulinaemia. Helv Paediatr Acta. 1973 Dec;28(6):553–558. [PubMed] [Google Scholar]
  33. Mosier D. E., Johnson B. M. Ontogeny of mouse lymphocyte function. II. Development of the ability to produce antibody is modulated by T lymphocytes. J Exp Med. 1975 Jan 1;141(1):216–226. doi: 10.1084/jem.141.1.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Paglieroni T., MacKenzie M. R. Studies on the pathogenesis of an immune defect in multiple myeloma. J Clin Invest. 1977 Jun;59(6):1120–1133. doi: 10.1172/JCI108736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Rádl J., Masopust J., Jodl J., Kithier K. Paraproteinemia in the pregnant woman and in her child. II. Transient paraproteinemia in the child. Helv Paediatr Acta. 1968 Oct;23(5):555–563. [PubMed] [Google Scholar]
  36. SOLOMON A., WALDMANN T. A., FAHEY J. L. Clinical and experimental metabolism of normal 6.6s gamma-globulin in normal subjects and in patients with macroglobulinemia and multiple myeloma. J Lab Clin Med. 1963 Jul;62:1–17. [PubMed] [Google Scholar]
  37. Shakib F., Hardwicke J., Stanworth D. R., White R. H. Asymmetric depression in the serum level of IgG subclasses in patients with nephrotic syndrome. Clin Exp Immunol. 1977 Jun;28(3):506–511. [PMC free article] [PubMed] [Google Scholar]
  38. Soothill J. F., Hayes K., Dudgeon J. A. The immunoglobulins in congenital rubella. Lancet. 1966 Jun 25;1(7452):1385–1388. doi: 10.1016/s0140-6736(66)90299-6. [DOI] [PubMed] [Google Scholar]
  39. Soothill J. F. Immunoglobulins in first-degree relatives of patients with hypogammaglobulinaemia. Transient hypogammaglobulinaemia: a possible manifestation of heterozygocity. Lancet. 1968 May 11;1(7550):1001–1003. doi: 10.1016/s0140-6736(68)91110-0. [DOI] [PubMed] [Google Scholar]
  40. South M. A., Montgomery J. R., Rawls W. E. Immune deficiency in congenital rubella and other viral infections. Birth Defects Orig Artic Ser. 1975;11(1):234–238. [PubMed] [Google Scholar]
  41. Tanapatchaiyapong P., Zolla S. Humoral immunosuppressive substance in mice bearing plasmacytomas. Science. 1974 Nov 22;186(4165):748–750. doi: 10.1126/science.186.4165.748. [DOI] [PubMed] [Google Scholar]
  42. Waldmann T. A., Durm M., Broder S., Blackman M., Blaese R. M., Strober W. Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia. Lancet. 1974 Sep 14;2(7881):609–613. doi: 10.1016/s0140-6736(74)91940-0. [DOI] [PubMed] [Google Scholar]
  43. Waldmann T. A., Johnson J. S., Talal N. Hypogammaglobulinemia associated with accelerated catabolism of IgG secondary to its inteaction with an IgG-reactive monoclonal IgM. J Clin Invest. 1971 Apr;50(4):951–959. doi: 10.1172/JCI106567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Waldmann T. A., Strober W. Metabolism of immunoglobulins. Prog Allergy. 1969;13:1–110. doi: 10.1159/000385919. [DOI] [PubMed] [Google Scholar]
  45. Waldmann T. A., Strober W., Mogielnicki R. P. The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia. J Clin Invest. 1972 Aug;51(8):2162–2174. doi: 10.1172/JCI107023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Warner T. F., Krueger R. G. Circulating lymphocytes and the spread of myeloma. Review of the evidence. Lancet. 1978 Jun 3;1(8075):1174–1176. doi: 10.1016/s0140-6736(78)90966-2. [DOI] [PubMed] [Google Scholar]
  47. Wochner R. D., Drews G., Strober W., Waldmann T. A. Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: a hereditary error of immunoglobulin catabolism. J Clin Invest. 1966 Mar;45(3):321–329. doi: 10.1172/JCI105346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Yakulis V., Bhoopalam N., Schade S., Heller P. Surface immunoglobulins of circulating lymphocytes in mouse plasmacytoma. I. Characteristics of lymphocyte surface immunoglobulins. Blood. 1972 Apr;39(4):453–464. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology. Supplement (Royal College of Pathologists). are provided here courtesy of BMJ Publishing Group

RESOURCES